Harpagoside

Details

Top
Internal ID 84963779-74c3-4cc1-8ad8-2eb7911be132
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Iridoid O-glycosides
IUPAC Name [(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
SMILES (Canonical) CC1(CC(C2(C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O)OC(=O)C=CC4=CC=CC=C4
SMILES (Isomeric) C[C@@]1(C[C@H]([C@]2([C@@H]1[C@@H](OC=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O)OC(=O)/C=C/C4=CC=CC=C4
InChI InChI=1S/C24H30O11/c1-23(35-16(27)8-7-13-5-3-2-4-6-13)11-15(26)24(31)9-10-32-22(20(23)24)34-21-19(30)18(29)17(28)14(12-25)33-21/h2-10,14-15,17-22,25-26,28-31H,11-12H2,1H3/b8-7+/t14-,15-,17-,18+,19-,20-,21+,22+,23+,24-/m1/s1
InChI Key KVRQGMOSZKPBNS-FMHLWDFHSA-N
Popularity 309 references in papers

Physical and Chemical Properties

Top
Molecular Formula C24H30O11
Molecular Weight 494.50 g/mol
Exact Mass 494.17881177 g/mol
Topological Polar Surface Area (TPSA) 175.00 Ų
XlogP -0.60
Atomic LogP (AlogP) -1.20
H-Bond Acceptor 11
H-Bond Donor 6
Rotatable Bonds 6

Synonyms

Top
19210-12-9
E-harpagoside
UNII-8KGS1DC5ZU
8KGS1DC5ZU
EINECS 242-881-6
CHEBI:5625
[(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-7-yl] (E)-3-phenylprop-2-enoate
SMR001233395
Harpaside
(1S-(1alpha,4aalpha,5alpha,7alpha(E),7aalpha))-1,4a,5,6,7,7a-Hexahydro-4a,5-dihydroxy-7-methyl-7-((allyl-1-oxo-3-phenyl)oxy)cyclopenta(c)pyran-1-yl-beta-D-glucopyranoside
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Harpagoside

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6494 64.94%
Caco-2 - 0.8532 85.32%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.8714 87.14%
Subcellular localzation Mitochondria 0.6045 60.45%
OATP2B1 inhibitior - 0.8544 85.44%
OATP1B1 inhibitior + 0.8588 85.88%
OATP1B3 inhibitior + 0.9525 95.25%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.6513 65.13%
P-glycoprotein inhibitior - 0.6537 65.37%
P-glycoprotein substrate - 0.7381 73.81%
CYP3A4 substrate + 0.6551 65.51%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8809 88.09%
CYP3A4 inhibition - 0.8888 88.88%
CYP2C9 inhibition - 0.9436 94.36%
CYP2C19 inhibition - 0.9025 90.25%
CYP2D6 inhibition - 0.9231 92.31%
CYP1A2 inhibition - 0.9046 90.46%
CYP2C8 inhibition + 0.6525 65.25%
CYP inhibitory promiscuity - 0.8689 86.89%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.5848 58.48%
Eye corrosion - 0.9928 99.28%
Eye irritation - 0.9532 95.32%
Skin irritation - 0.7650 76.50%
Skin corrosion - 0.9496 94.96%
Ames mutagenesis - 0.6370 63.70%
Human Ether-a-go-go-Related Gene inhibition + 0.7139 71.39%
Micronuclear - 0.6400 64.00%
Hepatotoxicity - 0.8065 80.65%
skin sensitisation - 0.8591 85.91%
Respiratory toxicity + 0.6222 62.22%
Reproductive toxicity + 0.7778 77.78%
Mitochondrial toxicity + 0.6375 63.75%
Nephrotoxicity - 0.7449 74.49%
Acute Oral Toxicity (c) III 0.5445 54.45%
Estrogen receptor binding + 0.7357 73.57%
Androgen receptor binding + 0.6687 66.87%
Thyroid receptor binding + 0.6197 61.97%
Glucocorticoid receptor binding - 0.4708 47.08%
Aromatase binding + 0.5968 59.68%
PPAR gamma + 0.6694 66.94%
Honey bee toxicity - 0.8379 83.79%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.5355 53.55%
Fish aquatic toxicity + 0.7676 76.76%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.71% 91.11%
CHEMBL221 P23219 Cyclooxygenase-1 97.02% 90.17%
CHEMBL1293249 Q13887 Kruppel-like factor 5 96.19% 86.33%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.36% 96.09%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 94.60% 96.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.38% 95.56%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 90.53% 94.62%
CHEMBL1806 P11388 DNA topoisomerase II alpha 90.47% 89.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 88.42% 97.09%
CHEMBL5028 O14672 ADAM10 84.13% 97.50%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 83.13% 94.08%
CHEMBL2581 P07339 Cathepsin D 82.23% 98.95%
CHEMBL3401 O75469 Pregnane X receptor 81.16% 94.73%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 80.14% 95.83%

Cross-Links

Top
PubChem 5281542
NPASS NPC276047
ChEMBL CHEMBL516702
LOTUS LTS0049528
wikiData Q25099323